Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HOPE Trial: Helping Our Patients Excel, and The SMART Study: Symptom Management and Reporting

NCT03022032 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT03022032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03022032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HOPE Trial: Helping Our Patients Excel, and The SMART Study: Symptom Management and Reporting
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2017
Completion date
September 2, 2020
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynecologic cancer